Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Lineage Cell Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common Shares, no par value | ||||||||||||||||||||||||||
| Equity | Preferred Shares, no par value | |||||||||||||||||||||||||||
| Debt | Debt Securities | |||||||||||||||||||||||||||
| Other | Warrants | |||||||||||||||||||||||||||
| Unallocated (Universal) Shelf) | — | 457(o | ) | (1 | ) | (2 | ) | $200,000,000 (2) | $ | 0.00014760 | $ | 29,520(3 | ) | |||||||||||||||
| Fees Previously Paid | — | — | — | — | — | — | — | |||||||||||||||||||||
| Total Offering Amounts | $ | 200,000,000 | $ | 29,520 | ||||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||||||
| Net Fee Due | $ | 29,520 | ||||||||||||||||||||||||||
| (1) | There are being registered hereunder such indeterminate number of common shares, such indeterminate number of preferred shares, such indeterminate principal amount of debt securities and such indeterminate number of warrants to purchase common share, preferred shares or debt securities as shall have an aggregate initial offering price not to exceed $200,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The securities registered also include such indeterminate number of common shares and preferred shares and principal amount of debt securities as may be issued upon conversion of or exchange for preferred shares or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of common shares and preferred shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. | |
| (2) | The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.F. of Form S-3 under the Securities Act. | |
| (3) | Calculated pursuant to Rule 457(o) under the Securities Act. |